Looking for a new barrier therapy for GERD?
June 2021
RefluG™ Isorepair is a patented class IIa medical device for the treatment of gastroesophageal reflux symptoms, available for out-licensing under private label. In ready-to-take liquid sachets, it exerts multiple mechanical actions on the esophageal mucosa surface (protective, soothing, lubricant). Its efficacy is proven in a randomized, double-blind placebo-controlled trial.
Gut Health
Verb Biotics’ Keystone Postbiotic enriches 33 beneficial gut species, trial finds
A clinical trial and mechanistic study on Verb Biotics’ Keystone ingredient find that the oat-based postbiotic enriched 33 beneficial “keystone” gut bacteria, reduced 38 taxa linked to gastrointestinal distress,...
Gut Health
ADM unpacks postbiotics and strain-specific microbiome clinical trials
Expanding research on the gut microbiome and its connections to other health areas is driving product development in the nutrition industry. ADM says advances in women’s health metabolites, the gut-brain axis, and...
Gut Health
Study warns prebiotic sodas’ “health halo” may mask limited fiber and gut benefits
A study, presented at the ongoing Nutrition 2026 (July 25–28) flagship annual meeting of the American Society for Nutrition, revealed that prebiotic sodas may contain more sugar and less fiber than marketed on the product...
Upcoming webinars
The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis
Register now
From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot
Register now
Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients
Register now
